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SHORT COMMUNICATION
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Diet restriction has repeatedly been shown to reduce the
incidence of spontaneous and chemically induced tumors in
rodents. However, no conclusive data are available to show
whether carcinogenesis by chronic exposure to a genotoxic
agent can also be retarded. In this study, diet restriction to
70% was investigated for a protective effect on the formation
of skin papilloma in male NMRI mice treated twice weekly
with 20 nmol 7,12-dimethylbenz[a]anthracene (DMBA).
Rather surprisingly, no protection was seen. Both time of
onset of papilloma formation (13 weeks in both groups) and
time of 50% cumulative incidence (fg,; 17.5 and 18 weeks)
were similar in the unrestricted and the restricted group. In
contrast, a dearly protective effect was found in mice initiated
with 100 nmol DMBA and promoted twice weekly with 2.5
nmol 12-Otetradecanoylphorbol-13-acetate: the onset of
papilloma formation increased from 7 to 11.5 weeks, the t^
was shifted from 8.5 to 19 weeks. Diet restriction, therefore,
was not protective under conditions of chronic exposure to
a genotoxic carcinogen. It cannot be considered a universal
measure of cancer prevention.
A large number of experimental studies have demonstrated that
diet restriction markedly reduces both spontaneous and chemically
induced tumor formation in mice and rats (1-17). A number
of reviews are also available (18-21). Reports on experiments
where restriction had no protective effect are rare (10). It
therefore appears as if reduction of food intake could be regarded
as a universal cancer-preventive measure.
In the majority of the investigations on chemically induced
tumor induction, the carcinogen was given as a single dose
(10,12-14) or for up to 4 weeks (5,7,10,15). In few studies,
the treatment with the carcinogen lasted longer but was stopped
either before the appearance of the first tumor (2—4) or when
the first tumor appeared in the unrestricted group (1). It therefore
remains to be shown whether the process of carcinogenesis can
be retarded by diet restriction under conditions of chronic
administration of a genotoxic agent. To answer this question, the
skin tumor model with NMRI mice and chronic administration
of 7,12-dimethylbenz[a]anthracene (DMBA*) was used (22-24).
Restriction was by feed reduction to 70%, a level chosen on the
basis of the findings that underfeeding at a level of 60% was
well tolerated and indistinguishable from caloric (carbohydrate)
restriction to 60% with respect to body weight and tumor
incidence (16).
Male NMRI mice [CrhNMRI BR] were obtained from Charles
River Savo, Kisslegg, Germany, at 6 weeks of age. The mice
•Abbreviations: DMBA, 7,12-dimethylbenz[<2]anthracene; TPA, 12-O-tetra-
decanoylphorbol-13-acetate; B[a]P, benzo[a]pyrene.
were housed individually at 21 ± 1°C with a 12 h light/dark
cycle in Macrolon cages type n . Feed (Nafag 890 from Nafag
AG, Gossau, Switzerland) and water were given ad libitum to
all mice from 6 to 8 weeks of age. The backs of the mice were
shaved at week 7 (a swatch 4 cm long, 3 cm wide; Wella
Minicut). One week later, restriction and treatment was started.
The restricted mice were given weighed feed portions amounting
to 70% of the feed eaten by the unrestricted group. Every evening
at 6.30 p.m., i.e. 30 min before the beginning of the dark phase,
a rotating wheel delivered the weighed portions into the feed
compartment of the cages. The size of the portions was adjusted
weekly on the basis of the weighed feed intake by the unrestricted
group.
Treatment A (chronic administration of DMBA): starting at
week 0, 60 mice (30 ad libitum, 30 restricted) received twice
weekly a dermal application of 20 nmol DMBA (Sigma) in 0.1
ml acetone on the shaved part of die back until 4 days before
diey were killed. Application solution was prepared biweekly and
was stored at -20°C. One mouse in each group died
spontaneously during the experiment. Treatment B (initiation with
DMBA, promotion with 12-0-tetradecanoylphorbol-13-acetate
[TPA]; positive control for a protective effect of diet restriction):
twenty-eight mice (14 ad libitum, 14 restricted) were treated once
with 100 nmol DMBA in 0.1 ml acetone (= week 0). Treatment
with 2.5 nmol TPA (LC Services Corporation, Woburn, MA),
twice weekly in 0.1 ml acetone, was started 1 week later. A TPA
stock solution (8 X) was prepared once, divided into 5 ml aliquots
and stored at -20°C. Two mice of the restricted group died
spontaneously during the experiment. Controls: two groups of
mice (9 ad libitum, 9 restricted) were treated twice weekly widi
0.1 ml acetone.
All mice were visually inspected and palpated for papillomas
twice weekly and were weighed biweekly. They were killed 2
weeks after showing the first, persistent papilloma with diameter
> 1 mm.
Body weights are given in Figure 1. Diet restriction resulted
in a significant reduction in body weight under bom treatments.
In the initiation—promotion model (Figure 1; treatment B), the
initial decrease appeared to be faster, probably because of some
high-dose effect of the initiating 100 nmol DMBA. The initiation
might also be the reason why the weight gain in the unrestricted
group of treatment B was slower than in treatment A. The weight
curves for the control groups treated with acetone alone were
not different from those seen with treatment A (data not shown).
The cumulative skin-papilloma incidence is shown in Figure 2.
Unexpectedly, diet restriction had no protective effect when die
mice were treated chronically with DMBA (Figure 2A). Both
time of onset of papilloma formation (13 weeks) and time of 50%
cumulative incidence (tx; 17.5 and 18 weeks) were similar in
both groups. A papilloma incidence of 100% was reached after
25 and 28 weeks in unrestricted and restricted animals
respectively.
In contrast, and as expected from die literature (16), diet
restriction had a clearly protective effect in the initiation—
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Fig. 1. Body weights of male NMRI mice fed ad libitum (open circles) or
restricted to 70% feed intake (full circles). Treatment A (group size at start
30): 20 nmol DMBA twice weeldy, starting at week 0. Treatment B (group
size at start: 14): initiation with 100 nmol DMBA at week 0, followed by
promotion with 2.5 nmol TPA twice weeldy, starting at week 1. Data are
given as mean weights ± 1 SD.
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Fig. 2. Cumulative incidence of skin papillomas in male NMRI mice fed ad
libitum (solid line) or restricted to 70% feed intake (dashed line). Treatment
A: 20 nmol DMBA twice weekly, starting at week 0. Treatment B:
initiation with 100 nmol DMBA at week 0, followed by promotion with 2.5
nmol TPA twice weeldy, starting at week 1.
promotion model (Figure 2B). The onset of papilloma formation
increased from 7 to 11.5 weeks, the fjo was shifted from 8.5
to 19 weeks. The papilloma incidence in the unrestricted group
was 100% after 13 weeks and it would have taken much longer
to reach 100% in the restricted group. Histological examination
of the papillomas did not reveal any observable differences
between the four groups. In the acetone control groups, no tumor
was recorded within 28 weeks of observation. For controls treated
only with DMBA (1 x 100 nmol) or TPA (10 nmol twice weekly),
the papilloma incidence within 24 weeks had been reported to
be 0 or 4% (22).
Our negative data are in contrast to Tannenbaum's early
findings mentioned above (1—4). The discrepancy could be due
to the use of different carcinogens and different dose levels. The
5 /tg DMBA dose used here and the 60 ng benzo[a]pyrene (B[a]P)
dose used by Tannenbaum (1,3) can be considered equicarcino-
genic (25,26) but the relative importance of genotoxic versus
promoting activity associated with the repeated administration
of the two carcinogens could be different. For DMBA,
carcinogenicity might be dominated by genotoxicity while the
10-fold higher chemical dose of B[a]P could include a more
pronounced 'promotional' activity. Such an explanation would
also be in line with recent work by Birt and co-workers who
showed that diet restriction had a beneficial effect only when
applied during tumor promotion but not during initiation (16).
It could be argued that a dose of 20 nmol DMBA twice weekly
was too high to allow restriction to come into play. The possibility
that high doses of carcinogen could override the effects of diet
restriction was mentioned by Tannenbaum and Silverstone in their
review article (18). However, the dose used here did not result
in a maximum rate of the process of carcinogenesis. While we
observed a median latency time of 17.5 weeks, dose levels of
25, 50 and 100 nmol resulted in t^ values of 16, 12.5 and 11
weeks respectively (24). Furthermore, the initiation—promotion
protocol used in treatment B resulted in an even fester appearance
of the papillomas in the unrestricted group and still allowed diet
restriction to be protective. The question of whether diet
restriction can retard the process of papilloma formation therefore
strongly depends on the mechanism of action. It appears as if
clonal expansion of initiated cells during tumor promotion could
be reduced by diet restriction but that the rate of accumulation
of critical mutations from chronic exposure to a genotoxic agent
is not affected.
Our results suggest that diet restriction is not protective under
all circumstances of chronic exposure to a carcinogen. Whether
or not there is an effect depends upon the specific mechanism
of carcinogenesis. For a situation of chronic high-dose exposure
of mouse skin to a genotoxic agent the formation of papilloma
could not be reduced. Although the data do not give any
information on the process of tumor progression to carcinoma,
they strongly indicate that diet restriction should not be considered
a universal cancer-preventive measure.
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